HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Visceral Leishmaniasis (Kala Azar)

A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
Also Known As:
Kala Azar; Leishmaniasis, Visceral; Fever, Black; Black Fever; Kala-Azar
Networked: 2641 relevant articles (286 outcomes, 332 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Infection
2. Visceral Leishmaniasis (Kala Azar)
3. Leishmaniasis
4. Cutaneous Leishmaniasis
5. Acquired Immunodeficiency Syndrome (AIDS)

Experts

1. Sundar, Shyam: 111 articles (08/2015 - 09/2002)
2. Dube, Anuradha: 37 articles (08/2015 - 11/2004)
3. Boelaert, Marleen: 34 articles (10/2015 - 01/2004)
4. Sundar, S: 31 articles (07/2015 - 03/2000)
5. Das, Pradeep: 30 articles (02/2016 - 01/2008)
6. Pandey, Krishna: 24 articles (02/2016 - 01/2005)
7. Salotra, Poonam: 24 articles (10/2015 - 04/2004)
8. Reis, Alexandre Barbosa: 24 articles (07/2015 - 06/2004)
9. Ali, Nahid: 24 articles (01/2015 - 12/2002)
10. Roy, Syamal: 23 articles (03/2015 - 06/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Visceral Leishmaniasis:
1. liposomal amphotericin BFDA Link
2. Amphotericin B (Amphotericin)FDA LinkGeneric
3. miltefosineIBA
4. AntigensIBA
5. AntimonyIBA
6. Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA
7. Liposomes (Liposome)IBA
8. Fluorometholone (FML)FDA Link
9. Paromomycin (Paromomycin Sulfate)FDA LinkGeneric
10. SaponinsIBA

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Aftercare (After-Treatment)
3. Immunotherapy
4. Injections
5. Oral Administration